The National Football League has signed its first-ever pharmaceutical partner in a multi-year deal with Switzerland-based firm Novartis , a league source told Reuters on Thursday.

American football’s elite National Football League (NFL) has brought in US medicine company Novartis as the property's first-ever pharmaceutical partner. Novartis, granted exclusivity in the corporate pharmaceutical partnership category,

Novartis has teamed up with the NFL in a multi-year partnership, marking the first such collaboration between the football league and a pharmaceutical company. | Novartis has teamed up with the NFL in a multi-year partnership,

The NFL have signed its first-ever pharmaceutical partner in a multi-year deal with Novartis to focus on the NFL’s health initiatives, including its annual health and safety summit, as well as its 'Crucial Catch' cancer awareness program.

Novartis, a pharmaceuticals company, and the National Football League have announced an unprecedented partnership that names Novartis as the official first-in-category corporate pharmaceutical partner of the NFL.

The NFL has inked a multi-year deal with pharmaceutical giant Novartis, marking its first such partnership. This collaboration will spotlight health initiatives like cancer awareness. It strategically aligns Novartis with the influential league amid potential U.